Tradestie Institutional Equity Comparison Engine

IG vs ICCC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ICCC Overall Edge

ICCC Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immucell Corp (ICCC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, IG trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ICCC at N/M Forward P/E and 15.2% operating margin (+11.5% YoY). In options structure, IG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ICCC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ICCC
IG N/M vs ICCC N/M Fwd P/E
Growth & Margin Winner ICCC
Op Margin N/A vs 15.2% ยท YoY N/A vs +11.5%
Momentum & Technical Winner ICCC
1Y -6.1% vs +88.8% ยท 52W Pos 14% vs 91%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IG NYSE Arca
Principal Investment Grade Corporate Active ETF
Institutional Equity
$19.61
-0.02% 1D
Market Cap N/A
1M Return -0.61%
1Y Return -6.14%
Forward P/E N/M
Unified AI Score
45.4 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 46.0
ICCC NASDAQ
Immucell Corp
In Vitro & In Vivo Diagnostic Substances
$11.42
+6.23% 1D
Market Cap $97.7M
1M Return +6.23%
1Y Return +88.76%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 48.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IG -6.14% ICCC +88.76% Spread: +94.9 pp (ICCC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IG TTM Op. Margin: N/A ICCC TTM Op. Margin: 15.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IG vs ICCC. Trailing 12-month operating profitability (IG N/A vs ICCC 15.2%) and valuation multiples (IG N/M vs ICCC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IG (2) vs ICCC (7)
Institutional Metric IG ICCC Criterion Row Winner
Market Capitalization Scale N/A $97.7M Larger Scale ICCC
Trailing P/E Ratio Valuation N/M 56.6x Lower Multiple ICCC
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +11.5% Higher Growth ICCC
Operating Margin (TTM) Profitability N/A 15.2% Higher Margin ICCC
Net Profit Margin Profitability N/A 2.6% Higher Margin ICCC
Return on Equity (ROE) Capital Efficiency N/A 2.6% Higher ROE ICCC
52-Week Range Position Momentum 14% ($19โ€“$21) 91% ($5โ€“$12) Stronger Trend ICCC
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 7% Vol 0.24ฮฒ ยท 46% Vol Lower Realized Risk IG
Unified Institutional Score Composite Signal 45.4 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite IG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IG vs ICCC Buy Guide
IG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ICCC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ICCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IG nor ICCC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.